Manufacturing Depression: the placebo story
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. Larry Kaskel is joined by psychotherapist and freelance journalist Dr. Gary Greenberg who participated in a clinical trial for a new anti-depression medication. He discusses the fact that in over half the trials used to approve the six leading anti-depressants, the drugs failed to outperform the placebo. He also speaks about the discovery of a pattern of brain activity that is common to those subjects who respond to the placebo.
Overview
Dr. Larry Kaskel is joined by psychotherapist and freelance journalist Dr. Gary Greenberg who participated in a clinical trial for a new anti-depression medication. He discusses the fact that in over half the trials used to approve the six leading anti-depressants, the drugs failed to outperform the placebo. He also speaks about the discovery of a pattern of brain activity that is common to those subjects who respond to the placebo.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Phase 3 study results of plozasiran in patients with FCS
FCS and SHTG: Are We Meeting the Need?
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
HF Management for Patients with Comorbid Conditions
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?